Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Liu, Yiwen  [Clear All Filters]
2016
Zhang L, Xiang L, Liu Y, Venkatraman P, Chong L, Cho J, Bonilla S, Jin Z-B, Pang CPui, Ko KMing, et al. A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration. PLoS One. 2016;11(3):e0149663.
2019
Sun J, Li G, Liu Y, Ma M, Song K, Li H, Zhu D, Tang X, Kong J, Yuan X. Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma. Neoplasia. 2019;22(1):33-46.
2021
Yang H, Liu Y, Kong J. Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma. Transl Oncol. 2021;14(11):101204.
2022
Guo Q, Qiu Y, Liu Y, He Y, Zhang G, Du Y, Yang C, Gao F. Cell adhesion molecule CD44v10 promotes stem-like properties in triple-negative breast cancer cells via glucose transporter GLUT1-mediated glycolysis. J Biol Chem. 2022:102588.
Shimony S, Liu Y, Valtis YK, Paolino JD, Place AE, Brunner AM, Weeks LD, Silverman LB, Vrooman LM, Neuberg D, et al. Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood Adv. 2022.
2023
Li R, Liu Y, Zhou F, Yang H, Li J, Dai N, Sun W, Kong J, Gao S. Clinical Significance of Enriching Cancer Stem Cells by Inhibiting Programmed Cell Death Factor 4 in Esophageal Squamous Cell Carcinoma. ACS Infect Dis. 2023.